XML 21 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2015
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s condensed consolidated statements of operations for the three and six months ended September 30, 2015 and 2014:

 

     For the Three Months Ended
September 30,
     For the Six Months Ended
September 30,
 
     2015      2014      2015      2014  
     (in $000’s)      (in $000’s)  

Cost of product revenue

   $ 218       $ 148       $ 455       $ 357   

Research and development

     989         773         1,920         1,626   

Selling, general and administrative

     9,586         3,103         13,217         6,331   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 10,793       $ 4,024       $ 15,592       $ 8,314   
  

 

 

    

 

 

    

 

 

    

 

 

 
Components of Stock-Based Compensation

The components of stock-based compensation for the three and six months ended September 30, 2015 and 2014 were as follows:

 

     For the Three Months Ended
September 30,
     For the Six Months Ended
September 30,
 
     2015      2014      2015      2014  
     (in $000’s)      (in $000’s)  

Restricted stock units

   $ 8,446       $ 3,334       $ 12,349       $ 6,754   

Stock options

     2,227         624         3,046         1,423   

Employee stock purchase plan

     120         66         197         137   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 10,793       $ 4,024       $ 15,592       $ 8,314   
  

 

 

    

 

 

    

 

 

    

 

 

 
Summary of Stock Option Activity

The following table summarizes the stock option activity for the six months ended September 30, 2015:

 

     Options
(in thousands)
     Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Term
(years)
     Aggregate
Intrinsic
Value
(in thousands)
 

Outstanding at beginning of period

     2,892       $ 14.72         5.18      

Granted

     145         69.50         

Exercised

     (703      11.33         

Cancelled and expired

     (1      14.00         
  

 

 

    

 

 

       

Outstanding at end of period

     2,333       $ 19.16         5.56       $ 172,712   
  

 

 

    

 

 

       

Exercisable at end of period

     1,696       $ 13.76         4.50       $ 134,674   
  

 

 

    

 

 

       

Options vested and expected to vest at end of period

     2,277       $ 18.98         5.50       $ 169,000   
  

 

 

    

 

 

       
Weighted-Average Assumptions Used to Calculate Fair Value of Options Granted

The fair value of options granted during the three and six months ended September 30, 2015 and 2014 were calculated using the following weighted average assumptions:

 

     For the Three Months Ended
September 30,
    For the Six Months Ended
September 30,
 
     2015     2014     2015     2014  

Risk-free interest rate

     1.63     1.75     1.59     1.60

Expected option life (years)

     4.13        4.19        4.14        4.19   

Expected volatility

     48.3     48.7     49.7     49.3
Time Based Restricted Stock and Restricted Stock Units  
Summary of Restricted Stock and Restricted Stock Units Activity

The following table summarizes the activity of restricted stock and restricted stock units for the six months ended September 30, 2015:

 

    

Number of

Shares

    

Weighted

Average

Grant Date

Fair Value

 
     (in thousands)      (per share)  

Restricted stock and restricted stock units at beginning of period

     1,160       $ 21.90   

Granted

     655       $ 80.70   

Vested

     (461    $ 22.55   

Forfeited

     (42    $ 13.09   
  

 

 

    

 

 

 

Restricted stock and restricted stock units at end of period

     1,312       $ 51.31   
  

 

 

    

 

 

 
Restricted stock units  
Monte Carlo Simulation Model to Estimate Grant-Date Fair Value of Restricted Stock Units

The table below sets forth the assumptions used to value the awards and the estimated grant-date fair value:

 

Risk-free interest rate

     1.10

Dividend yield

     0

Remaining performance period (years)

     2.96   

Expected volatility

     47.2

Estimated grant date fair value (per share)

   $ 107.10   

Target performance (number of shares)

     107,660